Trial intelligence / Profile preview

Switching to Ropinirole CR in Parkinson's Disease

NCT00465452Phase 3Completed

Sponsor
The University of Toledo
Start
Jan 2007
Primary completion
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ropinirole in Parkinson's disease (PD), sponsored by The University of Toledo. Started Jan 2007; status: completed.

02

Drugs

ropinirole
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT00465452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00465452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call